These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33983051)

  • 1. Real-world effectiveness and tolerability of Zelesse cream® for treating vulvovaginitis in adult women: an observational, prospective study.
    Masero AR; Frutos LMS; Vizcaíno E; Palma M; Velasco-Ortega S; Nieto C
    J Int Med Res; 2021 May; 49(5):3000605211013226. PubMed ID: 33983051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptability, tolerability, and effects on symptoms and signs of vulvovaginitis of a non-soap, herbal-based intimate hygiene solution (Zelesse®).
    Guinot M; Blanco JE; Delgado JL; Oliva R; Frutos LMS; Huerta I; Velasco S; Nieto C
    J Int Med Res; 2019 Jun; 47(6):2626-2636. PubMed ID: 31088247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy, acceptability and tolerability of Zelesse® for the treatment of non-specific vulvovaginitis in paediatric patients: The NINESSE Study.
    García F; Rodríguez CA; Palomo ML; Català P; Fernández S; Huerta I; Velasco S; Nieto C;
    J Int Med Res; 2018 Sep; 46(9):3583-3595. PubMed ID: 29877120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of non-hormonal remedies for vaginal dryness: open, prospective, randomized trial.
    Stute P; May TW; Masur C; Schmidts-Winkler IM
    Climacteric; 2015; 18(4):582-9. PubMed ID: 25845406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome Symptom.
    Archer DF; Kimble TD; Lin FDY; Battucci S; Sniukiene V; Liu JH
    J Womens Health (Larchmt); 2018 Mar; 27(3):231-237. PubMed ID: 29193980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical treatment of vaginal dryness with a non-hormonal cream in women undergoing breast cancer treatment - An open prospective multicenter study.
    Chatsiproios D; Schmidts-Winkler IM; König L; Masur C; Abels C
    PLoS One; 2019; 14(1):e0210967. PubMed ID: 30677065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is vaginal hyaluronic acid as effective as vaginal estriol for vaginal dryness relief?
    Stute P
    Arch Gynecol Obstet; 2013 Dec; 288(6):1199-201. PubMed ID: 24178484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of a plant-based, multi-component cream (Ginetrox®) in vulvovaginal disorders of the genitourinary syndrome during menopause.
    Marrai R; Lissi G; Togni S; Maramaldi G; Barbara M; Giacomelli L
    Minerva Ginecol; 2017 Jun; 69(3):245-249. PubMed ID: 28420227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study of soft gel technology: a new vaginal device to improve the symptomatology of vulvovaginal atrophy in post-partum, menopause and in patients with recurrent vulvovaginitis.
    Maniglio P; Ricciardi E; Meli F; De Marco MP; Costanzi F; Caserta D
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6035-6044. PubMed ID: 31364105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of raloxifene on the response to conjugated estrogen vaginal cream or nonhormonal moisturizers in postmenopausal vaginal atrophy.
    Parsons A; Merritt D; Rosen A; Heath H; Siddhanti S; Plouffe L;
    Obstet Gynecol; 2003 Feb; 101(2):346-52. PubMed ID: 12576260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trial shows lasting function of a new moisturizing cream against vaginal dryness.
    Henneicke-von Zepelin HH; Williams R; Havemeister W; Wigger-Alberti W; Nolte KU
    Wien Med Wochenschr; 2017 May; 167(7-8):189-195. PubMed ID: 28091974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of low-dose regimens of conjugated estrogens cream administered vaginally.
    Bachmann G; Bouchard C; Hoppe D; Ranganath R; Altomare C; Vieweg A; Graepel J; Helzner E
    Menopause; 2009; 16(4):719-27. PubMed ID: 19436223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Comparison of vaginal cream of mixing yogurt, honey and clotrimazole on symptoms of vaginal candidiasis.
    Darvishi M; Jahdi F; Hamzegardeshi Z; Goodarzi S; Vahedi M
    Glob J Health Sci; 2015 Apr; 7(6):108-16. PubMed ID: 26153168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a sulfonamide vaginal cream post partum. A controlled "blind" study of 700 patients.
    RUBIN A
    Am J Obstet Gynecol; 1961 Oct; 82():860-2. PubMed ID: 14494895
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the Effects of Fenugreek Vaginal Cream and Ultra Low- Dose Estrogen on Atrophic Vaginitis.
    Safary M; Hakimi S; Mobaraki-Asl N; Amiri P; Tvassoli H; Delazar A
    Curr Drug Deliv; 2020; 17(9):815-822. PubMed ID: 32640956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preliminary evaluation of a vaginal cream containing lactoferrin in the treatment of vulvovaginal candidosis].
    Costantino D; Guaraldi C
    Minerva Ginecol; 2008 Apr; 60(2):121-5. PubMed ID: 18487962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of terconazole. European experience.
    Hirsch HA
    J Reprod Med; 1989 Aug; 34(8 Suppl):593-6. PubMed ID: 2677364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical experience in the use of 0.5% and 1% benzydamine cream in vaginal inflammation].
    Mega M; Becagli L
    Minerva Ginecol; 1986; 38(7-8):625-30. PubMed ID: 3748443
    [No Abstract]   [Full Text] [Related]  

  • 19. Fenticonazole nitrate for treatment of vulvovaginitis: efficacy, safety, and tolerability of 1-gram ovules, administered as ultra-short 2-day regimen.
    Fernández-Alba J; Valle-Gay A; Dibildox M; Vargas JA; González J; García M; López LH;
    J Chemother; 2004 Apr; 16(2):179-86. PubMed ID: 15216954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, multicenter, double-blind study to evaluate the safety and efficacy of estradiol vaginal cream 0.003% in postmenopausal women with dyspareunia as the most bothersome symptom.
    Kroll R; Archer DF; Lin Y; Sniukiene V; Liu JH
    Menopause; 2018 Feb; 25(2):133-138. PubMed ID: 28926514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.